Tubal ligation and risk of ovarian cancer subtypes: a pooled analysis of case-control studies
Author(s) -
Weiva Sieh,
Shan Salvador,
Valerie McGuire,
Rachel Palmieri Weber,
Kathryn L. Terry,
Mary Anne Rossing,
Harvey A. Risch,
Anna H. Wu,
Penelope M. Webb,
Kirsten B. Moysich,
Jennifer A. Doherty,
Anna Felberg,
Dianne Miller,
Susan J. Jordan,
Marc T. Goodman,
Galina Lurie,
Jenny ChangClaude,
Anja Rudolph,
Susanne K. Kjær,
Allan Jensen,
Estrid Høgdall,
Elisa V. Bandera,
Sara H. Olson,
Melony G King,
Lorna Rodríguez-Rodríguez,
Lambertus A. Kiemeney,
Tamara Marees,
Leon F.A.G. Massuger,
Anne M. van Altena,
Roberta B. Ness,
Daniel W. Cramer,
Malcolm C. Pike,
Celeste Leigh Pearce,
Andrew Berchuck,
Joellen M. Schildkraut,
Alice S. Whittemore
Publication year - 2013
Publication title -
international journal of epidemiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.406
H-Index - 208
eISSN - 1464-3685
pISSN - 0300-5771
DOI - 10.1093/ije/dyt042
Subject(s) - tubal ligation , ovarian cancer , medicine , ligation , case control study , oncology , risk factor , gynecology , cancer , research methodology , family planning , population , environmental health
Tubal ligation is a protective factor for ovarian cancer, but it is unknown whether this protection extends to all invasive histological subtypes or borderline tumors. We undertook an international collaborative study to examine the association between tubal ligation and ovarian cancer subtypes.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom